240 related articles for article (PubMed ID: 24046455)
21. Differential pathways of angiotensin II-induced extracellularly regulated kinase 1/2 phosphorylation in specific cell types: role of heparin-binding epidermal growth factor.
Shah BH; Yesilkaya A; Olivares-Reyes JA; Chen HD; Hunyady L; Catt KJ
Mol Endocrinol; 2004 Aug; 18(8):2035-48. PubMed ID: 15143154
[TBL] [Abstract][Full Text] [Related]
22. Caveolin-1 negatively regulates a metalloprotease-dependent epidermal growth factor receptor transactivation by angiotensin II.
Takaguri A; Shirai H; Kimura K; Hinoki A; Eguchi K; Carlile-Klusacek M; Yang B; Rizzo V; Eguchi S
J Mol Cell Cardiol; 2011 Mar; 50(3):545-51. PubMed ID: 21172357
[TBL] [Abstract][Full Text] [Related]
23. Angiotensin II-induced migration of vascular smooth muscle cells is mediated by p38 mitogen-activated protein kinase-activated c-Src through spleen tyrosine kinase and epidermal growth factor receptor transactivation.
Mugabe BE; Yaghini FA; Song CY; Buharalioglu CK; Waters CM; Malik KU
J Pharmacol Exp Ther; 2010 Jan; 332(1):116-24. PubMed ID: 19797620
[TBL] [Abstract][Full Text] [Related]
24. Distinct ADAM metalloproteinases regulate G protein-coupled receptor-induced cell proliferation and survival.
Schäfer B; Marg B; Gschwind A; Ullrich A
J Biol Chem; 2004 Nov; 279(46):47929-38. PubMed ID: 15337756
[TBL] [Abstract][Full Text] [Related]
25. Reactive oxygen species mediate Met receptor transactivation by G protein-coupled receptors and the epidermal growth factor receptor in human carcinoma cells.
Fischer OM; Giordano S; Comoglio PM; Ullrich A
J Biol Chem; 2004 Jul; 279(28):28970-8. PubMed ID: 15123705
[TBL] [Abstract][Full Text] [Related]
26. Role of transactivation of the EGF receptor in signalling by G-protein-coupled receptors.
Daub H; Weiss FU; Wallasch C; Ullrich A
Nature; 1996 Feb; 379(6565):557-60. PubMed ID: 8596637
[TBL] [Abstract][Full Text] [Related]
27. Lysophosphatidic acid-induced transactivation of epidermal growth factor receptor regulates cyclo-oxygenase-2 expression and prostaglandin E(2) release via C/EBPbeta in human bronchial epithelial cells.
He D; Natarajan V; Stern R; Gorshkova IA; Solway J; Spannhake EW; Zhao Y
Biochem J; 2008 May; 412(1):153-62. PubMed ID: 18294142
[TBL] [Abstract][Full Text] [Related]
28. Heparin blockade of thrombin-induced smooth muscle cell migration involves inhibition of epidermal growth factor (EGF) receptor transactivation by heparin-binding EGF-like growth factor.
Kalmes A; Vesti BR; Daum G; Abraham JA; Clowes AW
Circ Res; 2000 Jul; 87(2):92-8. PubMed ID: 10903991
[TBL] [Abstract][Full Text] [Related]
29. Choline Kinase α Mediates Interactions Between the Epidermal Growth Factor Receptor and Mechanistic Target of Rapamycin Complex 2 in Hepatocellular Carcinoma Cells to Promote Drug Resistance and Xenograft Tumor Progression.
Lin XM; Hu L; Gu J; Wang RY; Li L; Tang J; Zhang BH; Yan XZ; Zhu YJ; Hu CL; Zhou WP; Li S; Liu JF; Gonzalez FJ; Wu MC; Wang HY; Chen L
Gastroenterology; 2017 Apr; 152(5):1187-1202. PubMed ID: 28065789
[TBL] [Abstract][Full Text] [Related]
30. Protein kinase Calpha mediates feedback inhibition of EGF receptor transactivation induced by Gq-coupled receptor agonists.
Santiskulvong C; Rozengurt E
Cell Signal; 2007 Jun; 19(6):1348-57. PubMed ID: 17307332
[TBL] [Abstract][Full Text] [Related]
31. Epidermal growth factor receptor transactivation by endogenous vasoactive peptides contributes to hyperproliferation of vascular smooth muscle cells of SHR.
Li Y; Lévesque LO; Anand-Srivastava MB
Am J Physiol Heart Circ Physiol; 2010 Dec; 299(6):H1959-67. PubMed ID: 20852045
[TBL] [Abstract][Full Text] [Related]
32. HER/ErbB receptor interactions and signaling patterns in human mammary epithelial cells.
Zhang Y; Opresko L; Shankaran H; Chrisler WB; Wiley HS; Resat H
BMC Cell Biol; 2009 Oct; 10():78. PubMed ID: 19878579
[TBL] [Abstract][Full Text] [Related]
33. Angiotensin II stimulates ERK via two pathways in epithelial cells: protein kinase C suppresses a G-protein coupled receptor-EGF receptor transactivation pathway.
Li X; Lee JW; Graves LM; Earp HS
EMBO J; 1998 May; 17(9):2574-83. PubMed ID: 9564040
[TBL] [Abstract][Full Text] [Related]
34. Cholesterol depletion inhibits epidermal growth factor receptor transactivation by angiotensin II in vascular smooth muscle cells: role of cholesterol-rich microdomains and focal adhesions in angiotensin II signaling.
Ushio-Fukai M; Hilenski L; Santanam N; Becker PL; Ma Y; Griendling KK; Alexander RW
J Biol Chem; 2001 Dec; 276(51):48269-75. PubMed ID: 11585822
[TBL] [Abstract][Full Text] [Related]
35. Nitric oxide inhibits angiotensin II-induced activation of the calcium-sensitive tyrosine kinase proline-rich tyrosine kinase 2 without affecting epidermal growth factor receptor transactivation.
Wang D; Yu X; Brecher P
J Biol Chem; 1999 Aug; 274(34):24342-8. PubMed ID: 10446212
[TBL] [Abstract][Full Text] [Related]
36. Angiotensin II-induced process of angiogenesis is mediated by spleen tyrosine kinase via VEGF receptor-1 phosphorylation.
Buharalioglu CK; Song CY; Yaghini FA; Ghafoor HU; Motiwala M; Adris T; Estes AM; Malik KU
Am J Physiol Heart Circ Physiol; 2011 Sep; 301(3):H1043-55. PubMed ID: 21642504
[TBL] [Abstract][Full Text] [Related]
37. A role for Gab1/SHP2 in thrombin activation of PAK1: gene transfer of kinase-dead PAK1 inhibits injury-induced restenosis.
Wang D; Paria BC; Zhang Q; Karpurapu M; Li Q; Gerthoffer WT; Nakaoka Y; Rao GN
Circ Res; 2009 May; 104(9):1066-75. PubMed ID: 19359598
[TBL] [Abstract][Full Text] [Related]
38. EGFR drives the progression of AKI to CKD through HIPK2 overexpression.
Xu L; Li X; Zhang F; Wu L; Dong Z; Zhang D
Theranostics; 2019; 9(9):2712-2726. PubMed ID: 31131063
[TBL] [Abstract][Full Text] [Related]
39. Increased angiotensin II-mediated Src signaling via epidermal growth factor receptor transactivation is associated with decreased C-terminal Src kinase activity in vascular smooth muscle cells from spontaneously hypertensive rats.
Touyz RM; Wu XH; He G; Salomon S; Schiffrin EL
Hypertension; 2002 Feb; 39(2 Pt 2):479-85. PubMed ID: 11882594
[TBL] [Abstract][Full Text] [Related]
40. EGF transregulates opioid receptors through EGFR-mediated GRK2 phosphorylation and activation.
Chen Y; Long H; Wu Z; Jiang X; Ma L
Mol Biol Cell; 2008 Jul; 19(7):2973-83. PubMed ID: 18463167
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
